Home > LILACS - Literatura Latinoamericana y del Caribe de Ciencias de la Salud > Search result

Results: 5

Disfunción inmunológica en enfermedad de Alzheimer; proinflamatoria en etapas iniciales y regulatoria, y exhausta en etapas avanzadas
Immune dysfunction in disease Alzheimer's; proinflammatory in stages initial and regulatory, and exhaustive in advanced stages

Romero U. , César Antonio; Rogers C. , Nicole; San Martín R. , Carol; López N. , Mercedes; Behrens P. , María Isabel.
Rev. Hosp. Clin. Univ. Chile; 33 (3), 2022
Alzheimer disease (AD) is the main cause of dementia worldwide and a source of important population morbidity and mortality. It is estimate that its prevalence will increase dramatically in the upcoming years. The classical clinical presentation of AD is an amnesic hippocampal syndrome, and Mild Cognitiv...
Enfermedad de Alzheimer/inmunología, Enfermedad de Alzheimer/fisiopatología, Demencia/inmunología
Fulltext

Alzheimer's disease and cytokine IL-10 gene polymorphisms: is there an association?

Magalhães, Carolina Antunes; Carvalho, Maria das Graças; Sousa, Lirlândia Pires de; Caramelli, Paulo; Gomes, Karina Braga.
Arq. neuropsiquiatr; 75 (9), 2017
ABSTRACT Alzheimer's disease (AD) is the most common form of dementia. In the last 15 years, a new theory has proposed the autoimmune mechanism as a trigger for AD. Studies on the association between AD and inflammatory biomarkers have yielded controversial results. Interleukin-10 (IL-10), an anti-inflam...
Enfermedad de Alzheimer/genética, Enfermedad de Alzheimer/inmunología, Biomarcadores, Progresión de la Enfermedad, Interleucina-10/genética, Polimorfismo Genético
Fulltext

Amyloid-beta immunotherapy: the hope for Alzheimer disease?

Barrera-Ocampo, Alvaro; Lopera, Francisco.
Colomb. med; 47 (4), 2016
Abstract Alzheimer disease (AD) is the most prevalent form of dementia of adult-onset, characterized by progressive impairment in cognition and memory. There is no cure for the disease and the current treatments are only symptomatic. Drug discovery is an expensive and time-consuming process; in the last ...
Enfermedad de Alzheimer/terapia, Péptidos beta-Amiloides/inmunología, InmunoterapiaMétodos, Enfermedad de Alzheimer/inmunología, Enfermedad de Alzheimer/fisiopatología, Anticuerpos Monoclonales/farmacología, Anticuerpos Monoclonales/uso terapéutico, Progresión de la Enfermedad, Péptidos/farmacología, Péptidos/uso terapéutico
Fulltext

Evolutive levels of NGF in neurodegenerative disorders

Lorigados, L; Molina, H; Serrano, T; Pavón, N; Robinson, M. A; Alvarez, L; Soderstrom, S; Ebendal, T.
The two-site enzyme immunoassasy (EIA) using the monoclonal antibody (MAb) 27/21 is a valuable method capable of detecting mouse and human NGF quantitatively (Soderstrom et al., 1990). The presence of NGF in serum has been controversial, since t6he previous assay methods failed to detect circulating NGF....
Factores de Crecimiento Nervioso, Enfermedad de Alzheimer/inmunología, Enfermedad de Parkinson/inmunología, Enfermedad de Huntington/inmunología